Healthcare | September 12, 2023
Mpower unveils COPE to empower students to champion mental health in colleges
Mpower an initiative of Aditya Birla Education Trust works in the space of Mental health
Mpower an initiative of Aditya Birla Education Trust works in the space of Mental health
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Meningitis still affects more than 2.5 million people globally each year
Investigational cellular therapy, bemdaneprocel (BRT-DA01), was well tolerated with no major safety issues in all 12 participants in low dose and high dose cohorts through one year / At one-year
The 100 surgeries conducted using robotic technology span various intricate procedures in the fields of Urology, Liver Transplantation, GI surgery, Cardiac surgeries and Gynaecology
In Phase I studies, ZYIL1 was found to be safe and well-tolerated in human volunteers
LEO Pharma is developing delgocitinib cream for the treatment of moderate to severe chronic hand eczema, a hard-to-treat disease where there is a high unmet medical need for treatment
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
ELREXFIO’s label contains a boxed warning for cytokine release syndrome and neurologic toxicity
Subscribe To Our Newsletter & Stay Updated
